Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Therapeutics and Clinical Risk Management, 2018 Marco Proietti,1–3 Giuseppe Boriani4 1Department of Neuroscience, IRCCS – Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy; 2Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK ...
Proietti M, Boriani G
doaj
Anticoagulation: a practical guide for strabismus surgeons. [PDF]
, 2019 An increasing number of surgical strabismus patients are taking oral anticoagulant and antiplatelet agents, with more diverse mechanisms of action than those used in the past.
Frazer, Jeffrey R +3 more
core
Anticoagulants: Updates on idarucizumab [PDF]
British Dental Journal, 2017 J S, Chandan, T, Thomas, H S, Baryah
openaire +2 more sources
Idarucizumab in High-risk Thoracic Surgery
International Journal of Organ Transplantation Medicine, 2018 Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of ...
R L�pez Vilella +5 more
doaj
Utilizzo di Idarucizumab [PDF]
, 2019 Utilizzo in Toscana di idarucizumab, antidoto di ...
Lombardi Niccolò +8 more
openaire
Frontiers in Cardiovascular MedicineIntroductionPeriprocedural stroke represents a clinically important complication of atrial fibrillation ablation, and effective anticoagulation remains essential for risk reduction.
Bin Cai +5 more
doaj +1 more source
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases [PDF]
, 2017 core +1 more source
A dabigatran iv. antidótumának, az idarucizumabnak első hazai alkalmazásai sürgős műtétek esetén = The first uses of iv. idarucizumab for dabigatran reversal in cases of urgent surgeries in Hungary [PDF]
, 2017 Barabás, Éva +8 more
core +1 more source
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal [PDF]
, 2016 core +1 more source
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of CardiologyWorking Group on Cardiovascular Pharmacotherapy and European Society of CardiologyWorking Group on Thrombosis [PDF]
, 2015 Agewall, Stefan +15 more
core +1 more source